New Study: Global Human Immunodeficiency Virus (HIV) Infections (AIDS) Clinical Trials Review, H2, 2017

Researchmoz added Most up-to-date research on "New Study: Global Human Immunodeficiency Virus (HIV) Infections (AIDS) Clinical Trials Review, H2, 2017" to its huge collection of research reports.

GlobalData's clinical trial report, Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) clinical trials scenario. This report provides top line data relating to the clinical trials on Human Immunodeficiency Virus (HIV) Infections (AIDS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1354623

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse More Details @ https://www.researchmoz.us/human-immunodeficiency-virus-hiv-infections-aids-global-clinical-trials-review-h2-2017-report.html

Viral Infections In Global Market Till 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics

Researchmoz added Most up-to-date research on "Viral Infections In Global Market Till 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics" to its huge collection of research reports.

Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. 

The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Scope

The viral infections market is large and growing rapidly

• How do epidemiology trends differ among the key indications?
• What therapeutic options exist for preventing and treating viral infections?
• Which products and companies dominate the market?

The pipeline is innovative and diverse

• What is the proportion of early- to late-stage pipeline products?
• Which molecular targets are most prominent within the pipeline?
• How do the key indications differ in terms of molecule type?

Considerable market growth is anticipated throughout 2021

• Which products will contribute to this growth most significantly?
• Will the current market leaders retain their dominance over the forecast period?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=716911

Deal values for licensing and co-development deals range considerably

• How many strategic consolidations have been completed in the past decade?
• Which types of assets attract the largest deal values?

Reasons to buy

This report will allow you to -

• Examine the current clinical and commercial landscape by considering disease pathogenesis, treatment options and key marketed products.
• Appreciate how the four key indications - HIV, HCV, HBV and influenza - differ in terms of epidemiology, symptoms and co-morbidities and complications.
• Identify trends and developments, in terms of molecule type and molecular target, within the overall viral infections pipeline, as well as for each of the four key indications.
• Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates, by stage of development, key indication, molecule type and molecular target.
• Recognize how the evolving treatment landscape will drive market growth to 2021 and understand the contributions that different products, molecular targets and companies will make to this growth.
• Understand how strategic consolidations have shaped the current pipeline and marketed product landscapes.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=716911

Basic Overview Of Global Meningococcal Infections Vaccine Consumption Market For 2017

Researchmoz added Most up-to-date research on "Basic Overview Of Global Meningococcal Infections Vaccine Consumption Market For 2017" to its huge collection of research reports.

The Global Meningococcal Infections Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Meningococcal Infections Vaccine market.

First, the report provides a basic overview of the Meningococcal Infections Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Secondly, the report states the global Meningococcal Infections Vaccine market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.

Third, the Meningococcal Infections Vaccine market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Meningococcal Infections Vaccine industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=716437

Table of Contents

1 Industry Overview of Meningococcal Infections Vaccine

1.1 Definition and Specifications of Meningococcal Infections Vaccine

1.1.1 Definition of Meningococcal Infections Vaccine

1.1.2 Specifications of Meningococcal Infections Vaccine

1.2 Classification of Meningococcal Infections Vaccine

1.3 Applications of Meningococcal Infections Vaccine

1.4 Industry Chain Structure of Meningococcal Infections Vaccine

1.5 Industry Overview and Major Regions Status of Meningococcal Infections Vaccine

1.5.1 Industry Overview of Meningococcal Infections Vaccine

1.5.2 Global Major Regions Status of Meningococcal Infections Vaccine

1.6 Industry Policy Analysis of Meningococcal Infections Vaccine

1.7 Industry News Analysis of Meningococcal Infections Vaccine

2 Manufacturing Cost Structure Analysis of Meningococcal Infections Vaccine

2.1 Raw Material Suppliers and Price Analysis of Meningococcal Infections Vaccine

2.2 Equipment Suppliers and Price Analysis of Meningococcal Infections Vaccine

2.3 Labor Cost Analysis of Meningococcal Infections Vaccine

2.4 Other Costs Analysis of Meningococcal Infections Vaccine

2.5 Manufacturing Cost Structure Analysis of Meningococcal Infections Vaccine

2.6 Manufacturing Process Analysis of Meningococcal Infections Vaccine

3 3 Global Market Size (Volume and Value), Sales and Sale Price Analysis of Meningococcal Infections Vaccine

3.1 Global Market Size (Volume and Value) and Growth Rate of Meningococcal Infections Vaccine 2011-2016

3.2 Global Market Size (Volume and Value) of Meningococcal Infections Vaccine by Regions 2011-2016

3.3 Global Market Size (Volume and Value) of Meningococcal Infections Vaccine by Types 2011-2016

3.4 Global Market Size (Volume and Value) of Meningococcal Infections Vaccine by Applications 2011-2016

3.5 Global Sales Volume and Sales Revenue of Meningococcal Infections Vaccine by Companies 2011-2016

3.6 Global Sale Price of Meningococcal Infections Vaccine by Regions 2011-2016

3.7 Global Sale Price of Meningococcal Infections Vaccine by Types 2011-2016

3.8 Global Sale Price of Meningococcal Infections Vaccine by Applications 2011-2016

3.9 Global Sale Price of Meningococcal Infections Vaccine by Companies 2011-2016

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=716437

Meningococcal Infections Vaccine Market In United State During 2017

Researchmoz added Most up-to-date research on "Meningococcal Infections Vaccine Market In United State During 2017" to its huge collection of research reports.

This report studies sales (consumption) of Meningococcal Infections Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sanofi-Pasteur
Beijing Tiantan Biological Products
Shanghai Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Hualan Biological Engineering
Chongqing Zhifei Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Walvax Biotechnology
Royal(Wuxi) Bio-Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Meningococcal conjugate vaccines
Meningococcal polysaccharide vaccine
Serogroup B meningococcal vaccine

Split by applications, this report focuses on sales, market share and growth rate of Meningococcal Infections Vaccine in each application, can be divided into
For Children
For Preteens/Teens
For Adults

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=897676

Table of Contents

United States Meningococcal Infections Vaccine Market Report 2016
1 Meningococcal Infections Vaccine Overview
1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine
1.2.1 Meningococcal conjugate vaccines
1.2.2 Meningococcal polysaccharide vaccine
1.2.3 Serogroup B meningococcal vaccine
1.3 Application of Meningococcal Infections Vaccine
1.3.1 For Children
1.3.2 For Preteens/Teens
1.3.3 For Adults
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Meningococcal Infections Vaccine (2011-2021)
1.4.1 United States Meningococcal Infections Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Meningococcal Infections Vaccine Revenue and Growth Rate (2011-2021)

2 United States Meningococcal Infections Vaccine Competition by Manufacturers
2.1 United States Meningococcal Infections Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Meningococcal Infections Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Meningococcal Infections Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Meningococcal Infections Vaccine Market Competitive Situation and Trends
2.4.1 Meningococcal Infections Vaccine Market Concentration Rate
2.4.2 Meningococcal Infections Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=897676

2017 - 2020: Antifungal Global Market With Focus on Invasive Fungal Infections

Researchmoz added Most up-to-date research on "2017 - 2020: Antifungal Global Market With Focus on Invasive Fungal Infections" to its huge collection of research reports.

The report titled Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020 provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Azole, Echinocandins and Polyene.

The report analysis the invasive fungal infection market extensively with the market size, in terms of value along with the market segments and the major products in the market. This section also provides information about the regional market share of the global invasive fungal infection market. The report provides detailed regional analysis of the United States, Europe and Latin America. The regional analysis of the antifungal market includes market size by value along with the geographic overview of the market in the concerned region.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global antifungal market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global antifungal market is stiff and dominated by the big players like Pfizer. Further, key players of the market, Merck and Scynexis are also profiled with their financial information and respective business strategies.

Regional Coverage
United States
Europe
Latin America

Company Coverage
Pfizer, Inc.
Merck Co., Inc.
Scynexis, Inc.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=841066

Executive Summary
The global antifungal market witnessed an upsurge at a significant CAGR during 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The market is spread across the globe with the United States and Europe dominating the market, while Asia-Pacific and Latin America market are the fastest growing markets.

The antifungal market can be segmented on the basis of types of drugs into Polyene, Azole and Echinocandins. The Azole class of antifungals dominates the market followed, by Echinocandins and Polyene. Azoles are broadly categorized as Voricanazole, Imidazole, Triazole and Thiazoles. Of which, Voricanazole govern the market. Echinocandins antifungal class is subjugated by Caspofungin, while other antifungals include Micafungin, and Anidulafungin. The Polyene antifungal agents include Amphotericin B, Nystatin, and Natamycin. Though, Amphotericin B is the only widely used agent in the market.

The fungal infections do not usually result in severe ailment, but in people with weak immune system, minor fungal infections can move in the bloodstreams and conquer critical organs leading to the damage, called as invasive fungal infection. The global market for the invasive fungal infection increased significantly during 2010-2015 and is expected to upsurge further.

The major growth drivers for the global antifungal market are: the rise in the incidences of fungal infection, aging population and unhygienic conditions all over the world. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: antifungal resistance, traditional treatments for fungal infection, side-effects of antifungal medication and antifungal development failures Some of the recent trends in the market include technological advancement, growth in resistant strains and generic competition.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=841066

Growth Of Global Gram-Positive Bacterial Infections Market During The Forecast Period 2017 - 2021

ResearchMoz presents this most up-to-date research on "Growth Of Global Gram-Positive Bacterial Infections Market During The Forecast Period 2017 - 2021".

Bacteria represents essential class of micro-organisms that play a crucial role in the development of infection of any disease to the human being and animal kingdom. Bacteria are divided into two types on the basis of gram staining test, namely; gram-positive bacteria and gram-negative bacteria.

Gram-positive bacteria retain the gram stain and hence are observed as violet purple colored stains when observed under microscope. These are distinguished from gram-negative bacteria, which are colored with red stains. Gram-positive bacteria represents the major class of bacteria and are responsible for infecting humans and animals with variety of acute and chronic diseases. Gram-positive bacteria are further divided on the basis of their shapes, such as, cocci and bacilli.

The market of gram-positive bacterial infections is segmented on the basis of various bacteria that belongs to the class, such as, bacillus, lactobacillus, actinomyces, clostridium, staphylococcus, streptococcus, listeria, enterococcus, mycobacterium, and many others. Further, the market is also segmented on the basis of diseases caused by gram-positive bacteria, such as, tuberculosis and other respiratory diseases, anthrax, newborn meningitis, acne, and many others. Moreover, it is segmented on the basis of antibacterial drugs, such as, B-lactum antibiotics (Penicillin), clavulanic acid (Augmentin), aminoglycosides (Streptomycin), glycopeptides (Vancomycin), polypeptides (Bacitracin), rifamycins (Rifampicin), chloramphenicol, tetracycline and many others. 

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=213299

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
• It provides distinctive graphics and exemplified SWOT analysis of major market segments

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=213299

2018 - 2022: Hospital Acquired Bacterial Infections (HABI) Global Market

Researchmoz added Most up-to-date research on "2018 - 2022: Hospital Acquired Bacterial Infections (HABI) Global Market" to its huge collection of research reports.

Hospital acquired bacterial infections (HABI) or nosocomial infections are type of infections commonly caused by bacterial pathogens and are acquired in healthcare facilities or hospitals. These pathogens should be examined in all patients who have developed some kind of clinical deterioration unexplained during the initial diagnosis. Currently, HABI market is a lucrative market venture due to increasing incidence rate of hospital acquired infections, which makes this industry a highly profitable and attractive market.

Some of the type of techniques and methods usually opted for performing various test for the diagnosis of hospital acquired bacterial infections are as follows:

• DNA Sequencing
• Colorimetric Methods
• Microarrays
• RT-PCR
• Solid-phase Hybridization Techniques
• Phage-based Assays
• The Nitrate Reductase Assay
• Phenotypic Methods

The following are the types of hospital acquired bacterial infections:

• Urinary Tract Infections (UTI)
• Pneumonia
• Blood Stream Infections (BSI)
• Surgical Site Infections

Some of the anti bacterial drug classes generally used for the treatment of HABI are as follows:

• Aminoglycosides
• B-Lactam Antibiotics
• Lincosamides
• Glycopeptides
• Carbapenems
• Macrolides
• Lipopeptides
• Polypeptides
• Quinolones
• Penicillins
• Sulfonamides
• Tetracyclines

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=216056

In the geographical analysis, North America is the leading market for hospital acquired bacterial infections treatment and testing market. Due to stringent hospital regulatory policies and increased government initiatives to prevent and control various hospital-acquired infections, this region is able to maintain its dominant position across the world. Europe closely follows North America is terms of growth, due to increasing incidence of hospital-acquired infections. According to the Health Protection Agency (HPA) approximately of patients in hospitals in England acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

This report provides comprehensive analysis of 

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
• It helps in understanding the key product segments and their future

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=216056

2021 Viral Infections Global Market | ResearchMoz

Researchmoz added Most up-to-date research on "2021 Viral Infections Global Market | ResearchMoz" to its huge collection of research reports.

Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Scope

The viral infections market is large and growing rapidly

• How do epidemiology trends differ among the key indications?
• What therapeutic options exist for preventing and treating viral infections?
• Which products and companies dominate the market?

The pipeline is innovative and diverse

• What is the proportion of early- to late-stage pipeline products?
• Which molecular targets are most prominent within the pipeline?
• How do the key indications differ in terms of molecule type?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=716911

Considerable market growth is anticipated throughout 2021

• Which products will contribute to this growth most significantly?
• Will the current market leaders retain their dominance over the forecast period?

Deal values for licensing and co-development deals range considerably

• How many strategic consolidations have been completed in the past decade?
• Which types of assets attract the largest deal values?

Reasons to buy

This report will allow you to -

• Examine the current clinical and commercial landscape by considering disease pathogenesis, treatment options and key marketed products.
• Appreciate how the four key indications - HIV, HCV, HBV and influenza - differ in terms of epidemiology, symptoms and co-morbidities and complications.
• Identify trends and developments, in terms of molecule type and molecular target, within the overall viral infections pipeline, as well as for each of the four key indications.
• Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates, by stage of development, key indication, molecule type and molecular target.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=716911